{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:35:22Z","timestamp":1780086922945,"version":"3.54.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Asia"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jacasi.2023.03.011","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T05:00:56Z","timestamp":1686891656000},"page":"625-633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Amplified Risk of Intracranial Artery\u00a0Stenosis\/Occlusion Associated\u00a0With\u00a0RNF213 p.R4810K in\u00a0Familial\u00a0Hypercholesterolemia"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2690-4318","authenticated-orcid":false,"given":"Kotaro","family":"Noda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yorito","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Nakaoku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3178-8171","authenticated-orcid":false,"given":"Takeshi","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Harada-Shiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacasi.2023.03.011_bib1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1474-4422(22)00165-X","article-title":"Moyamoya disease: diagnosis and interventions","volume":"21","author":"Ihara","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacasi.2023.03.011_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/jhg.2010.132","article-title":"A\u00a0genome-wide association study identifies RNF213 as the first moyamoya disease gene","volume":"56","author":"Kamada","year":"2011","journal-title":"J\u00a0Hum Genet"},{"key":"10.1016\/j.jacasi.2023.03.011_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12199-015-0498-7","article-title":"A\u00a0new horizon of moyamoya disease and associated health risks explored through RNF213","volume":"21","author":"Koizumi","year":"2016","journal-title":"Environ Health Prev Med"},{"key":"10.1016\/j.jacasi.2023.03.011_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1534\/g3.115.020321","article-title":"Disease variant landscape of a large multiethnic population of moyamoya patients by exome sequencing","volume":"6","author":"Shoemaker","year":"2016","journal-title":"G3 (Bethesda)"},{"key":"10.1016\/j.jacasi.2023.03.011_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/CIRCULATIONAHA.118.038439","article-title":"Moyamoya disease susceptibility variant RNF213 p.R4810K increases the risk of ischemic stroke attributable to large-artery atherosclerosis","volume":"139","author":"Okazaki","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2023.03.011_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep04442","article-title":"Moyamoya disease-associated protein mysterin\/RNF213 is a novel AAA+ ATPase, which dynamically changes its oligomeric state","volume":"4","author":"Morito","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacasi.2023.03.011_bib7","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/ejhg.2017.92","article-title":"Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians","volume":"25","author":"Guey","year":"2017","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jacasi.2023.03.011_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12199-012-0299-1","article-title":"P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure","volume":"18","author":"Koizumi","year":"2013","journal-title":"Environ Health Prev Med"},{"key":"10.1016\/j.jacasi.2023.03.011_bib9","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1161\/STROKEAHA.118.024712","article-title":"Prevalence of RNF213 p.R4810K variant in early-onset stroke with intracranial arterial stenosis","volume":"50","author":"Kamimura","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.jacasi.2023.03.011_bib10","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1161\/STROKEAHA.112.663864","article-title":"Identification of a genetic variant common to moyamoya disease and intracranial major artery stenosis\/occlusion","volume":"43","author":"Miyawaki","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.jacasi.2023.03.011_bib11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4103\/sni.sni_59_17","article-title":"Smaller outer diameter of atherosclerotic middle cerebral artery associated with RNF213 c.14576G>A Variant (rs112735431)","volume":"8","author":"Hongo","year":"2017","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.jacasi.2023.03.011_bib12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5551\/jat.CR003","article-title":"Guidelines for diagnosis and treatment of familial hypercholesterolemia. 2017","volume":"25","author":"Harada-Shiba","year":"2018","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.jacasi.2023.03.011_bib13","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1161\/CIRCULATIONAHA.118.033470","article-title":"Relationship of familial hypercholesterolemia and high low-density lipoprotein cholesterol to ischemic stroke: Copenhagen general population study","volume":"138","author":"Beheshti","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2023.03.011_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.atherosclerosis.2019.08.004","article-title":"Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients","volume":"289","author":"Hori","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacasi.2023.03.011_bib15","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1177\/23969873211012121","article-title":"European Stroke Organisation guideline on endarterectomy and stenting for carotid artery stenosis","volume":"6","author":"Bonati","year":"2021","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.jacasi.2023.03.011_bib16","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jacasi.2023.03.011_bib17","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0140-6736(95)92836-7","article-title":"Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts","volume":"346","author":"Collaboration","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jacasi.2023.03.011_bib18","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1161\/01.STR.0000057812.51734.FF","article-title":"Plasma lipid profile and incident ischemic stroke: The Atherosclerosis Risk in Communities (ARIC) Study","volume":"34","author":"Shahar","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.jacasi.2023.03.011_bib19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1161\/STROKEAHA.118.023456","article-title":"Risk of ischemic stroke and total cerebrovascular disease in familial hypercholesterolemia: a register study from Norway","volume":"50","author":"Hovland","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.jacasi.2023.03.011_bib20","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jacl.2017.03.019","article-title":"Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia","volume":"11","author":"Paquette","year":"2017","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacasi.2023.03.011_bib21","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.jacl.2018.08.006","article-title":"Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease","volume":"12","author":"Tada","year":"2018","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacasi.2023.03.011_bib22","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.5551\/jat.14621","article-title":"Guidelines for the management of familial hypercholesterolemia","volume":"19","author":"Harada-Shiba","year":"2012","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.jacasi.2023.03.011_bib23","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.STR.0000157667.06542.b7","article-title":"Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: The multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis","volume":"36","author":"Kwon","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jacasi.2023.03.011_bib24","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jacl.2015.12.024","article-title":"Proprotein convertase subtilisin\/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia","volume":"10","author":"Ohta","year":"2016","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacasi.2023.03.011_bib25","first-page":"1","article-title":"elrm: Software implementing exact-like inference for logistic regression models","volume":"21","author":"Zamar","year":"2007","journal-title":"J\u00a0Stat Softw"},{"key":"10.1016\/j.jacasi.2023.03.011_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2016.00039","article-title":"A\u00a0prospective study of asymptomatic intracranial atherosclerotic stenosis in neurologically normal volunteers in a Japanese cohort","volume":"7","author":"Matsui","year":"2016","journal-title":"Front Neurol"},{"key":"10.1016\/j.jacasi.2023.03.011_bib27","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1177\/1747493020908144","article-title":"Total small vessel disease score and cerebro-cardiovascular events in healthy adults: The Kashima scan study","volume":"15","author":"Suzuyama","year":"2020","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jacasi.2023.03.011_bib28","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.04.019","article-title":"RNF213 p.R4810K variant and intracranial arterial stenosis or occlusion in relatives of patients with moyamoya disease","volume":"26","author":"Matsuda","year":"2017","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jacasi.2023.03.011_bib29","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1161\/STROKEAHA.121.032616","article-title":"Stroke genetics: Turning discoveries into clinical applications","volume":"52","author":"Dichgans","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jacasi.2023.03.011_bib30","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1161\/STROKEAHA.120.032619","article-title":"Risk prediction using polygenic risk scores for prevention of stroke and other cardiovascular diseases","volume":"52","author":"Abraham","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jacasi.2023.03.011_bib31","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1161\/STROKEAHA.120.032617","article-title":"Mendelian randomization studies in stroke: Exploration of risk factors and drug targets with human genetic data","volume":"52","author":"Georgakis","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jacasi.2023.03.011_bib32","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1161\/STROKEAHA.121.032620","article-title":"Hereditary cerebral small vessel diseases and stroke: A guide for diagnosis and management","volume":"2","author":"Guey","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jacasi.2023.03.011_bib33","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/STROKEAHA.118.023972","article-title":"Clinical and molecular features of 5 European multigenerational families with moyamoya angiopathy","volume":"50","author":"Grangeon","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.jacasi.2023.03.011_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biomedicines8120550","article-title":"Molecular and cellular mechanisms of electronegative lipoproteins in cardiovascular diseases","volume":"8","author":"Ke","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.jacasi.2023.03.011_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcvm.2018.00130","article-title":"Endothelial transcytosis of lipoproteins in atherosclerosis","volume":"5","author":"Zhang","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacasi.2023.03.011_bib36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.fct.2018.01.022","article-title":"Dietary polyphenols: structures, bioavailability and protective effects against atherosclerosis","volume":"113","author":"Santhakumar","year":"2018","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.jacasi.2023.03.011_bib37","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/ajmg.a.38258","article-title":"RNF213 variants in a child with PHACE syndrome and moyamoya vasculopathy","volume":"173","author":"Schilter","year":"2017","journal-title":"Am J Med Genet Part A"},{"key":"10.1016\/j.jacasi.2023.03.011_bib38","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/STROKEAHA.120.032691","article-title":"Moyamoya disease susceptibility gene RNF213 regulates endothelial barrier function","volume":"55","author":"Roy","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.jacasi.2023.03.011_bib39","first-page":"1","article-title":"Biochemical and functional characterization of RNF213 (Mysterin) R4810K, a susceptibility mutation of moyamoya disease, in angiogenesis in\u00a0vitro and in\u00a0vivo","volume":"4","author":"Kobayashi","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacasi.2023.03.011_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-22064-8","article-title":"Dysregulation of RNF213 promotes cerebral hypoperfusion","volume":"8","author":"Morimoto","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacasi.2023.03.011_bib41","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.bbrc.2013.08.067","article-title":"The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431) induces genomic instability by mitotic abnormality","volume":"439","author":"Hitomi","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jacasi.2023.03.011_bib42","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1161\/STROKEAHA.120.030653","article-title":"Association between the onset pattern of adult moyamoya disease and risk factors for stroke","volume":"51","author":"Hirano","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.jacasi.2023.03.011_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175649","article-title":"Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease","volume":"12","author":"Morimoto","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jacasi.2023.03.011_bib44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41439-019-0059-5","article-title":"3.5KJPNv2: an allele frequency panel of 3552 Japanese individuals including the X chromosome","volume":"6","author":"Tadaka","year":"2019","journal-title":"Hum Genome Var"},{"key":"10.1016\/j.jacasi.2023.03.011_bib45","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/eurheartj\/ehx004","article-title":"Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia","volume":"38","author":"Tada","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2023.03.011_bib46","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jacl.2020.05.007","article-title":"The first Japanese cases of familial hypercholesterolemia due to a known pathogenic APOB gene variant, c.10580 G>A: p.(Arg3527Gln)","volume":"14","author":"Hori","year":"2020","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacasi.2023.03.011_bib47","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"}],"container-title":["JACC: Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374723000935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374723000935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T12:38:07Z","timestamp":1739018287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772374723000935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2772374723000935"],"URL":"https:\/\/doi.org\/10.1016\/j.jacasi.2023.03.011","relation":{},"ISSN":["2772-3747"],"issn-type":[{"value":"2772-3747","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amplified Risk of Intracranial Artery\u00a0Stenosis\/Occlusion Associated\u00a0With\u00a0RNF213 p.R4810K in\u00a0Familial\u00a0Hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"JACC: Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacasi.2023.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}